arrow
S

Simon Haefliger

Bern University Hospital
H指数:15
被引数:891

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)

TLD-1,一种新型脂质体多柔比星,在实体瘤患者中的比较药代动力学及一项多中心Ⅰ期研究(SAKK 65/16)的最终结果

2025-11-180
PRE
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma

一项关于口服lisavanbulin的剂量探索研究(1/2a期)及其生物标志物评估,用于治疗高级别胶质瘤或胶质母细胞瘤患者

2025-06-170
OA
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
2024-04-013
OAAI
Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities
2022-09-0112
OAAI
FIRST PHASE 2 RESULTS OF AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTE (TIL; LN-145) MONOTHERAPY IN PATIENTS WITH ADVANCED, IMMUNE CHECKPOINT INHIBITOR-TREATED, NON-SMALL CELL LUNG CANCER (NSCLC)
2021-11-1015
OA